N-Acetylcysteine

Amber

Brand Name(s):Unlicensed drug

Indication:Idiopathic pulmonary fibrosis

Rationale:

Considered:Jul-11

Review Date:Jul-22

Comments:
For management of IPF see:http://www.nice.org.uk/nicemedia/live/14183/64124/64124.pdf
NICE clinical guideline 163
June 2013

Refer to Shared Care documents on the medicines management website